These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1959559)
1. Cell growth stimulation by EGF: inhibition through antisense-oligodeoxynucleotides demonstrates important role of casein kinase II. Pepperkok R; Lorenz P; Jakobi R; Ansorge W; Pyerin W Exp Cell Res; 1991 Dec; 197(2):245-53. PubMed ID: 1959559 [TBL] [Abstract][Full Text] [Related]
2. Requirement of casein kinase 2 for entry into and progression through early phases of the cell cycle. Lorenz P; Pepperkok R; Pyerin W Cell Mol Biol Res; 1994; 40(5-6):519-27. PubMed ID: 7735326 [TBL] [Abstract][Full Text] [Related]
3. Cell biological studies with monoclonal and polyclonal antibodies against human casein kinase II subunit beta demonstrate participation of the kinase in mitogenic signaling. Lorenz P; Pepperkok R; Ansorge W; Pyerin W J Biol Chem; 1993 Feb; 268(4):2733-9. PubMed ID: 8428947 [TBL] [Abstract][Full Text] [Related]
4. Early cell growth stimulation is inhibited by casein kinase II antisense oligodeoxynucleotides. Pyerin W; Pepperkok R; Ansorge W; Lorenz P Ann N Y Acad Sci; 1992 Oct; 660():295-7. PubMed ID: 1340140 [No Abstract] [Full Text] [Related]
5. Human casein kinase II: structures, genes, expression and requirement in cell growth stimulation. Pyerin W Adv Enzyme Regul; 1994; 34():225-46. PubMed ID: 7942276 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human casein kinase II. A study with the complete set of subunits (alpha, alpha' and beta), site-directed autophosphorylation mutants and a bicistronically expressed holoenzyme. Bodenbach L; Fauss J; Robitzki A; Krehan A; Lorenz P; Lozeman FJ; Pyerin W Eur J Biochem; 1994 Feb; 220(1):263-73. PubMed ID: 8119294 [TBL] [Abstract][Full Text] [Related]
7. Casein kinase II is required for transition of G0/G1, early G1, and G1/S phases of the cell cycle. Pepperkok R; Lorenz P; Ansorge W; Pyerin W J Biol Chem; 1994 Mar; 269(9):6986-91. PubMed ID: 8120061 [TBL] [Abstract][Full Text] [Related]
8. Structure of the gene encoding human casein kinase II subunit beta. Voss H; Wirkner U; Jakobi R; Hewitt NA; Schwager C; Zimmermann J; Ansorge W; Pyerin W J Biol Chem; 1991 Jul; 266(21):13706-11. PubMed ID: 1856204 [TBL] [Abstract][Full Text] [Related]
9. An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Tortora G; Clair T; Cho-Chung YS Proc Natl Acad Sci U S A; 1990 Jan; 87(2):705-8. PubMed ID: 1689049 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Tortora G; Yokozaki H; Pepe S; Clair T; Cho-Chung YS Proc Natl Acad Sci U S A; 1991 Mar; 88(5):2011-5. PubMed ID: 2000408 [TBL] [Abstract][Full Text] [Related]
11. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Gal beta1, 4GlcNAc alpha2,6 sialyltransferase expression by antisense-oligodeoxynucleotides. Kemmner W; Hohaus K; Schlag PM FEBS Lett; 1997 Jun; 409(3):347-50. PubMed ID: 9224687 [TBL] [Abstract][Full Text] [Related]
13. Cell cycle effects of microinjected antisense oligodeoxynucleotides to p34cdc2 kinase. Mercer WE; Ullrich SJ; Shields MT; Lin D; Alder H Ann N Y Acad Sci; 1992 Oct; 660():209-18. PubMed ID: 1340123 [TBL] [Abstract][Full Text] [Related]
14. Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences. Chaikof EL; Caban R; Yan CN; Rao GN; Runge MS J Biol Chem; 1995 Mar; 270(13):7431-6. PubMed ID: 7706289 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria. Grankowski N; Boldyreff B; Issinger OG Eur J Biochem; 1991 May; 198(1):25-30. PubMed ID: 2040287 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of protein kinase CKII isoforms in HeLa cells. Isoform-specific differences in rates of assembly from catalytic and regulatory subunits. Chester N; Yu IJ; Marshak DR J Biol Chem; 1995 Mar; 270(13):7501-14. PubMed ID: 7706297 [TBL] [Abstract][Full Text] [Related]
18. Human casein kinase II. The subunit alpha protein activates transcription of the subunit beta gene. Robitzki A; Bodenbach L; Voss H; Pyerin W J Biol Chem; 1993 Mar; 268(8):5694-702. PubMed ID: 8449932 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells. Steller MA; Delgado CH; Zou Z Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11970-4. PubMed ID: 8618825 [TBL] [Abstract][Full Text] [Related]
20. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Yao XR; Scott DW Proc Natl Acad Sci U S A; 1993 Sep; 90(17):7946-50. PubMed ID: 7690139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]